4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001193125-26-224545
Chief Financial Officer sold 17,717 shares at $12.86 ($227,841)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2026-05-14 | Sale 10b5-1 | −17,717 | $12.86 | $227,841 | 195,178 | D: show line 1 in the form |
| Open-market sales · 17,717 sh · avg $12.86 · $227,841 | |||||||
Loading xslF345X06/ownership.xml…